Continuum Advisory’s Insmed INSM Stock Holding History

Continuum Advisory’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.14K	Buy	+67	New	+$8.11K	﹤0.01%	1363
2025 Q2	–	Sell	-27	Closed	-$2.06K	–	980
2025 Q1	$2.06K	Hold	27	–	–	﹤0.01%	1341
2024 Q4	$1.86K	Hold	27	–	–	﹤0.01%	1439
2024 Q3	$1.92K	Buy	27 +13	+93%	+$959	﹤0.01%	1440
2024 Q2	$938	Buy	+14	New	+$543	﹤0.01%	1486

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Continuum Advisory's INSM Position: Q2 2026 in Review

Continuum Advisory opened a new position in Insmed (INSM) in Q2 2026: 67 shares worth $7.14K. The stake represents ﹤0.01% of the portfolio and ranks #1363 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in INSM as recently as Q1 2025.

Continuum Advisory first reported a position in INSM in Q2 2024 and has held it in 5 quarters since. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Continuum Advisory held 67 shares of Insmed worth $7.14K as of Q2 2026.
Insmed was a new Continuum Advisory position in Q2 2026.
Insmed made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1363 holding.
Continuum Advisory first reported a position in Insmed in Q2 2024 and has held it in 5 quarters since.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.